je.st
news
UPDATE 1-CytRx's cancer treatment meets main goal, shares soar
2013-12-11 22:06:05| Biotech - Topix.net
CytRx Corp said its experimental cancer treatment improved survival rates in untreated soft tissue sarcoma patients without the disease progressing, compared with standard chemotherapy alone, sending the company's shares up as much as 83 percent.
Tags: main
update
treatment
goal
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||